TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
Presence of TP53 mutations has been associated with poor prognosis in diffuse large B-cell lymphoma (DLBCL), although this has remained controversial. The TP53 codon 72 polymorphism has shown negative impact on cancer survival, but this has not been analyzed in DLBCL. Furthermore, the MDM2 SNP309...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Limited
2008
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/1/Preview_of_%E2%80%9CUntitled_Document%E2%80%9D_tp53.pdf |
id |
iium-29949 |
---|---|
recordtype |
eprints |
spelling |
iium-299492016-12-08T01:37:18Z http://irep.iium.edu.my/29949/ TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype Zainuddin, Norafiza Berglund, Mattias Wanders, Alkwin Ren, Zhi-Ping Amini, Rose-Marie Lindell, Monica Kanduri, Meena Roos, Göran Rosenquist, Richard Enblad, Gunilla RC0254 Neoplasms. Tumors. Oncology (including Cancer) Presence of TP53 mutations has been associated with poor prognosis in diffuse large B-cell lymphoma (DLBCL), although this has remained controversial. The TP53 codon 72 polymorphism has shown negative impact on cancer survival, but this has not been analyzed in DLBCL. Furthermore, the MDM2 SNP309 has been associated with earlier age of onset in DLBCL. Here, we investigated the clinical impact of TP53 mutations,MDM2SNP309 and TP53 codon 72 polymorphisms on survival in DLBCL of germinal center (GC) and non-GC subtypes. Thirteen of the 102 (12.7%) patients displayed TP53 mutations. Overall, TP53 mutations had a significant effect on lymphoma-specific survival (LSS, P = 0.009) and progression-free survival (PFS, P = 0.028). In particular, inferior survival was observed in TP53-mutated DLBCLs of GC subtype (LSS, P = 0.002 and PFS, P = 0.006). Neither MDM2 SNP309 nor the TP53 codon 72 polymorphism had an impact on age of onset or survival. Altogether, our data suggests that TP53 mutations are associated with poor outcome in GC-DLBCL patients. Elsevier Limited 2008-08-15 Article PeerReviewed application/pdf en http://irep.iium.edu.my/29949/1/Preview_of_%E2%80%9CUntitled_Document%E2%80%9D_tp53.pdf Zainuddin, Norafiza and Berglund, Mattias and Wanders, Alkwin and Ren, Zhi-Ping and Amini, Rose-Marie and Lindell, Monica and Kanduri, Meena and Roos, Göran and Rosenquist, Richard and Enblad, Gunilla (2008) TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype. Leukemia Research, 33. pp. 60-66. ISSN 0145-2126 http://www.lrjournal.com/article/S0145-2126(10)00428-5/abstract doi:10.1016/j.leukres.2008.06.022 |
repository_type |
Digital Repository |
institution_category |
Local University |
institution |
International Islamic University Malaysia |
building |
IIUM Repository |
collection |
Online Access |
language |
English |
topic |
RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
spellingShingle |
RC0254 Neoplasms. Tumors. Oncology (including Cancer) Zainuddin, Norafiza Berglund, Mattias Wanders, Alkwin Ren, Zhi-Ping Amini, Rose-Marie Lindell, Monica Kanduri, Meena Roos, Göran Rosenquist, Richard Enblad, Gunilla TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype |
description |
Presence of TP53 mutations has been associated with poor prognosis in diffuse large B-cell lymphoma (DLBCL), although this has remained
controversial. The TP53 codon 72 polymorphism has shown negative impact on cancer survival, but this has not been analyzed in DLBCL.
Furthermore, the MDM2 SNP309 has been associated with earlier age of onset in DLBCL. Here, we investigated the clinical impact of TP53
mutations,MDM2SNP309 and TP53 codon 72 polymorphisms on survival in DLBCL of germinal center (GC) and non-GC subtypes. Thirteen
of the 102 (12.7%) patients displayed TP53 mutations. Overall, TP53 mutations had a significant effect on lymphoma-specific survival (LSS,
P = 0.009) and progression-free survival (PFS, P = 0.028). In particular, inferior survival was observed in TP53-mutated DLBCLs of GC
subtype (LSS, P = 0.002 and PFS, P = 0.006). Neither MDM2 SNP309 nor the TP53 codon 72 polymorphism had an impact on age of onset
or survival. Altogether, our data suggests that TP53 mutations are associated with poor outcome in GC-DLBCL patients. |
format |
Article |
author |
Zainuddin, Norafiza Berglund, Mattias Wanders, Alkwin Ren, Zhi-Ping Amini, Rose-Marie Lindell, Monica Kanduri, Meena Roos, Göran Rosenquist, Richard Enblad, Gunilla |
author_facet |
Zainuddin, Norafiza Berglund, Mattias Wanders, Alkwin Ren, Zhi-Ping Amini, Rose-Marie Lindell, Monica Kanduri, Meena Roos, Göran Rosenquist, Richard Enblad, Gunilla |
author_sort |
Zainuddin, Norafiza |
title |
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype |
title_short |
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype |
title_full |
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype |
title_fullStr |
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype |
title_full_unstemmed |
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype |
title_sort |
tp53 mutations predict for poor survival in de novo diffuse
large b-cell lymphoma of germinal center subtype |
publisher |
Elsevier Limited |
publishDate |
2008 |
url |
http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/ http://irep.iium.edu.my/29949/1/Preview_of_%E2%80%9CUntitled_Document%E2%80%9D_tp53.pdf |
first_indexed |
2023-09-18T20:43:58Z |
last_indexed |
2023-09-18T20:43:58Z |
_version_ |
1777409550689763328 |